FDA Loosens Restrictions on Diabetes Drug Avandia

Diabetes drug Avandia was linked to significantly increased risks of heart attack and cardiovascular death, prompting the FDA to restrict access to the drug in 2010 The FDA has announced it is lifting those restrictions to allow widespread access to the drug once again The decision was based on a heavily criticized study conducted by the drug’s maker, GlaxoSmithKline (which pleaded guilty to fraud in 2012 for failing to report safety problems with Avandia) .